Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Lincare Holdings, Inc
(“Lincare” or the “Company”) (Nasdaq: LNCR) relating to the proposed
acquisition by Linde AG. (“Linde”).
Under the terms of the transaction, Lincare shareholders will receive
only $41.50 in cash for each of Lincare stock they own. The
investigation concerns possible breaches of fiduciary duty and other
violations of state law by the Board of Directors of Lincare for not
acting in the Company’s shareholders' best interests in connection with
the sale process to Linde. The Board of Directors may have failed to
adequately shop the Company and may have undervalued Lincare resulting
in harm to the Lincare shareholders.
If you own shares of Lincare stock and wish to discuss the legal
ramifications of the proposed transaction, or have any questions, you
may e-mail or call the law office of Brodsky & Smith, LLC who will,
without obligation or cost to you, attempt to answer your questions. You
may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at
Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004,
by e-mail at investorrelations@brodsky-smith.com
visiting http://brodsky-smith.com/445-lncr-lincare-holdings-inc.html,
or by calling toll free 877-LEGAL-90.
